Given that LIN28B is known to be a key contributor to the formation of induced pluripotent stem (iPS) cells (58), it is possible that LIN28B is reprograming CRC cells to a more differentiated identity and fate through CDX2. This evidence concerns the gene LIN28B and colorectal carcinoma.